Evaluation of the Effect of Intradermal Dihydroquin Dos on Providing Sedation for Patients with Digestive Disease

Not Applicable

Recruiting

• Conditions: Effect of Intradermal Dosage Injection (PCDX).; Diseases of the digestive system; (K50-K52)

• Registration Number: IRCT20160103025821N6
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 March 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1650

Inclusion Criteria

Symptoms of diagnostic and endoscopic interventions of upper or lower GI procedures, or both
Male and female at least 18 years old
Otherwise, the patient is healthy or ill with mild systemic disease, which is well controlled
Urinalysis or pregnancy serum in female patients at the start of the study
Being able to provide informed consent is signed

Exclusion Criteria

Patients under the age of 18 years or those unable to sign an informed consent
Surgical procedures or those who have had an open surgical procedure for endoscopic surgery within one week
Chronic opioid use or benzodiazepine for anxiety, insomnia and chronic pain
Severe hyperactivity (heart rate <45 bpm)
Low blood pressure (systolic blood pressure less than 90 mmHg)
Advanced heartbeats, AV blocks, second and third grade, and a branch block of the sinusoidal bacillary block that is detected during the monitoring stages in the EKG, which lasts for more than 15 seconds
The chronic use of beta blockers, the calcium channel block, which may cause chronic diarrhea and life threatening bradycardia
Detection of ECG 12 Lead by QT. The patient will typically not be screened for this variable
Patients with upper and lower GI bleeding and patients with unstable hemodynamics
Pregnant pregnant women
Patients with advanced liver failure
Patients who have been treated with any drug in the last 30 days
Undesirable reactions to medications or predscheks in previous use
History of mental disorder or use of psychiatric drugs
Patients with pain in the intestinal tract
Gastrectomy history
There may be serious illnesses simultaneously

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ow blood pressure. Timepoint: mmediately after the intervention, after 5 minute, after 10 minute, after 20 minute, after 40 minute, after 60 minute, after 1.5 hour, after 2 hour, after 3 hour, . Method of measurement: Monitoring, Sphygmomanometer tool.;Nausea. Timepoint: Immediately after the intervention, after 5 minute, after 10 minute, after 20 minute, after 40 minute, after 60 minute, after 1.5 hour, after 2 hour, after 3 hour, . Method of measurement: Ask the patient.